9.00 USD
-0.40
4.26%
At close Jul 11, 4:00 PM EDT
After hours
9.00
+0.00
0.00%
1 day
-4.26%
5 days
-10.89%
1 month
-5.56%
3 months
-1.64%
6 months
-34.02%
Year to date
-34.92%
1 year
-51.90%
5 years
-64.75%
10 years
-64.75%
 

About: ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

Employees: 1,770

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

57% more call options, than puts

Call options by funds: $191K | Put options by funds: $122K

2.07% less ownership

Funds ownership: 85.26% [Q4 2024] → 83.19% (-2.07%) [Q1 2025]

4% less funds holding

Funds holding: 267 [Q4 2024] → 255 (-12) [Q1 2025]

23% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 30

24% less capital invested

Capital invested by funds: $328M [Q4 2024] → $249M (-$79.6M) [Q1 2025]

25% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 69

50% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 1 (-1) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$10
11%
upside
Avg. target
$10
11%
upside
High target
$10
11%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
UBS
Kevin Caliendo
11%upside
$10
Neutral
Maintained
15 May 2025

Financial journalist opinion

Positive
Seeking Alpha
4 weeks ago
ZimVie: Screening Cheap (Rating Upgrade)
ZimVie's stock has plunged over 40% since my downgrade, but recent cost reductions are improving profitability, and the stock is forming a bottoming pattern. Despite continued revenue declines, especially internationally, EBITDA margins have expanded and full-year guidance remains achievable. Valuation is now attractive, with ZIMV trading at a significant discount to dental implant peers on a Fwd EV/EBITDA basis.
ZimVie: Screening Cheap (Rating Upgrade)
Positive
Zacks Investment Research
1 month ago
ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite
ZIMV launches RealGUIDE Software Suite and Implant Concierge in Japan to boost digital dental workflows.
ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite
Neutral
GlobeNewsWire
1 month ago
ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite and Implant Concierge® Service in Japan
Innovative digital dentistry experience empowers greater efficiency, accuracy, and esthetic outcomes in dental care Innovative digital dentistry experience empowers greater efficiency, accuracy, and esthetic outcomes in dental care
ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite and Implant Concierge® Service in Japan
Neutral
GlobeNewsWire
1 month ago
ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference
PALM BEACH GARDENS, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming Stifel 2025 Jaws & Paws Conference. Management will be presenting on Wednesday, May 28, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time.
ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference
Neutral
Seeking Alpha
2 months ago
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript
ZimVie Inc. (NASDAQ:ZIMV ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Vafa Jamali - President & Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants Dylan Finley - UBS Anderson Schock - B. Riley Securities Matthew Miksic - Barclays Bank Operator Good afternoon, and welcome to ZimVie's First Quarter 2025 Earnings Conference Call.
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
2 months ago
ZimVie Reports First Quarter 2025 Financial Results
Net Sales from Continuing Operations of $112.0 million Net Loss from Continuing Operations of $(2.6) million; Net Loss margin of (2.3)% Adjusted EBITDA [ 1] from Continuing Operations of $17.6 million; Adjusted EBITDA [1] margin of 15.7% GAAP diluted EPS from Continuing Operations of $(0.09) and adjusted diluted EPS [1] from Continuing Operations of $0.27 PALM BEACH GARDENS, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter ended March 31, 2025.
ZimVie Reports First Quarter 2025 Financial Results
Neutral
GlobeNewsWire
2 months ago
ZimVie to Report First Quarter 2025 Financial Results on May 8, 2025
PALM BEACH GARDENS, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2025 after market close on Thursday, May 8, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
ZimVie to Report First Quarter 2025 Financial Results on May 8, 2025
Neutral
GlobeNewsWire
2 months ago
ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System
PALM BEACH GARDENS, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its Immediate Molar Implant System in the United States.
ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System
Neutral
GlobeNewsWire
3 months ago
ZimVie to Participate in the 24th Annual Needham Virtual Healthcare Conference
PALM BEACH GARDENS, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will be presenting on Tuesday, April 8, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time.
ZimVie to Participate in the 24th Annual Needham Virtual Healthcare Conference
Neutral
GlobeNewsWire
3 months ago
ZimVie Announces Upcoming Changes to Company's Board of Directors
PALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's Board of Directors, including:
ZimVie Announces Upcoming Changes to Company's Board of Directors
Charts implemented using Lightweight Charts™